| Literature DB >> 10916136 |
Abstract
The patenting of biological molecules, such as hybridomas and monoclonal antibodies, has become an important issue in biology. While challenging cherished beliefs and practices of many biologists, it has been a central issue for hybridoma and monoclonal antibody research.Mesh：
Substances：
Year: 2000 PMID： 10916136 DOI： 10.1016/s0167-5699(00)01688-1
Source DB: PubMed Journal: Immunol Today ISSN： 0167-5699